Total Payments
$3,461
2024 Payments
$419.84
Companies
41
Transactions
133
Medicare Patients
3,531
Medicare Billing
$600,898
Payment Breakdown by Category
Food & Beverage$3,255 (94.0%)
Other$200.00 (5.8%)
Education$6.08 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,255 | 131 | 94.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 5.8% |
| Education | $6.08 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $370.14 | 6 | $0 (2023) |
| Amgen Inc. | $354.69 | 12 | $0 (2023) |
| Novo Nordisk Inc | $324.14 | 16 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $229.76 | 10 | $0 (2024) |
| Vifor Pharma, Inc. | $221.97 | 2 | $0 (2021) |
| Allergan Inc. | $190.76 | 4 | $0 (2017) |
| OPKO Pharmaceuticals, LLC | $185.93 | 16 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $127.63 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $111.45 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $109.06 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $419.84 | 15 | REVANCE THERAPEUTICS, INC. ($72.23) |
| 2023 | $754.13 | 23 | Merz North America, Inc. ($171.90) |
| 2022 | $262.03 | 13 | Novo Nordisk Inc ($40.91) |
| 2021 | $519.18 | 17 | Vifor Pharma, Inc. ($221.97) |
| 2020 | $193.23 | 6 | MERZ NORTH AMERICA, INC. ($98.11) |
| 2019 | $660.82 | 33 | Amgen Inc. ($244.64) |
| 2018 | $181.12 | 8 | Horizon Pharma plc ($38.14) |
| 2017 | $470.71 | 18 | Allergan Inc. ($190.76) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Neurology | ||||||
| 11/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $72.23 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.78 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Obesity | ||||||
| 06/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Gastroenterology | ||||||
| 02/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: NEPHROLOGY | ||||||
| 02/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: IMMUNOLOGY | ||||||
| 02/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes Care | ||||||
| 01/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 01/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $34.90 | General |
| 12/14/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.02 | General |
| 12/05/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug) | Food and Beverage | In-kind items and services | $111.45 | General |
| Category: NEPHROLOGY | ||||||
| 09/28/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: Sleep | ||||||
| 09/07/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,038 | 1,868 | $402,921 | $168,087 |
| 2022 | 21 | 878 | 9,929 | $353,307 | $147,078 |
| 2021 | 23 | 825 | 15,164 | $329,479 | $155,995 |
| 2020 | 22 | 790 | 1,623 | $298,239 | $129,738 |
Total Patients
3,531
Total Services
28,584
Medicare Billing
$600,898
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 22 | 72 | $16,236 | $6,949 | 42.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 37 | $15,485 | $6,389 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 37 | 37 | $6,550 | $5,246 | 80.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 59 | 166 | $17,581 | $4,804 | 27.3% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 30 | 49 | $11,050 | $4,657 | 42.1% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 49 | 49 | $6,615 | $4,347 | 65.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $9,062 | $3,705 | 40.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 13 | $6,357 | $3,257 | 51.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 34 | 44 | $4,840 | $2,900 | 59.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 42 | $3,906 | $2,121 | 54.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 24 | $1,968 | $1,501 | 76.3% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2021 | 23 | 30 | $2,340 | $1,256 | 53.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 71 | $3,870 | $875.63 | 22.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 36 | 36 | $1,404 | $747.95 | 53.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 12 | $1,200 | $571.08 | 47.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 35 | 40 | $1,568 | $534.40 | 34.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 24 | $840.00 | $464.16 | 55.3% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2021 | 34 | 45 | $1,125 | $47.98 | 4.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 13 | 17 | $178.50 | $26.47 | 14.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 83 | 284 | $60,776 | $25,749 | 42.4% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 71 | 165 | $33,990 | $18,200 | 53.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 175 | $39,463 | $15,868 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 219 | $33,617 | $13,240 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 43 | 57 | $23,855 | $10,016 | 42.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 50 | 73 | $22,083 | $9,014 | 40.8% |
About Dr. Nasimeh Yazdani, M.D
Dr. Nasimeh Yazdani, M.D is a Nephrology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154376580.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nasimeh Yazdani, M.D has received a total of $3,461 in payments from pharmaceutical and medical device companies, with $419.84 received in 2024. These payments were reported across 133 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($3,255).
As a Medicare-enrolled provider, Yazdani has provided services to 3,531 Medicare beneficiaries, totaling 28,584 services with total Medicare billing of $600,898. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Santa Monica, CA
- Active Since 05/24/2006
- Last Updated 04/11/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154376580
Products in Payments
- Veltassa (Drug) $221.97
- Rayaldee (Drug) $185.93
- JYNARQUE (Drug) $184.99
- Xeomin (Biological) $171.90
- ACTHAR (Biological) $157.47
- BOTOX OAB (Drug) $133.91
- Wegovy (Drug) $129.50
- Aimovig (Biological) $121.62
- JESDUVROQ (Drug) $111.45
- LOKELMA (Drug) $109.06
- IBSRELA (Drug) $107.08
- Parsabiv (Biological) $104.22
- Saxenda (Drug) $103.39
- Kerendia (Drug) $85.98
- DAXXIFY (Drug) $72.23
- INJECTAFER (Drug) $67.59
- XIFAXAN (Drug) $65.92
- JARDIANCE (Drug) $63.68
- FREESTYLE LIBRE 3 (Device) $62.69
- Otezla (Drug) $60.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Santa Monica
Dr. Connie Rhee, M.d, M.D
Nephrology — Payments: $99,698
Nephrology $99,698
Reza Khorsan, M.d, M.D
Nephrology — Payments: $6,844
Nephrology $6,844
Dr. Earl Gordon, M.d, M.D
Nephrology — Payments: $2,471
Nephrology $2,471
Fawad Zafar-Khan, Md, MD
Nephrology — Payments: $2,129
Nephrology $2,129
Ying Hui Luu, M.d, M.D
Nephrology — Payments: $716.35
Nephrology $716.35
Mark Nachman, Md, MD
Nephrology — Payments: $165.28
Nephrology $165.28